Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 10/20 | 0.59 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.55 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.55 |
| ▸ | CASP2 | P42575 | 1/20 | 0.53 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.53 |
| ▸ | FAAH | O00519 | 1/20 | 0.50 |
| ▸ | NAAA | Q02083 | 1/20 | 0.50 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL146693 | 1.00 | EPHX1 (0.59) | EPHX1ZDHHC20ZDHHC2CASP2PLA2G2A | |
| SCHEMBL149561 | 1.00 | EPHX1 (0.59) | EPHX1ZDHHC20ZDHHC2CASP2PLA2G2A | |
| SCHEMBL148882 | 1.00 | EPHX1 (0.59) | EPHX1ZDHHC20ZDHHC2CASP2PLA2G2A | |
| SCHEMBL153838 | 1.00 | EPHX1 (0.59) | EPHX1ZDHHC20ZDHHC2CASP2PLA2G2A | |
| SCHEMBL372894 | 1.00 | EPHX1 (0.59) | EPHX1ZDHHC20ZDHHC2CASP2PLA2G2A | |
| SCHEMBL144546 | 1.00 | EPHX1 (0.59) | EPHX1ZDHHC20ZDHHC2CASP2PLA2G2A | |
| SCHEMBL14857009 | 1.00 | EPHX1 (0.59) | EPHX1ZDHHC20ZDHHC2CASP2PLA2G2A | |
| SCHEMBL149423 | 1.00 | EPHX1 (0.59) | EPHX1ZDHHC20ZDHHC2CASP2PLA2G2A | |
| SCHEMBL150597 | 1.00 | EPHX1 (0.59) | EPHX1ZDHHC20ZDHHC2CASP2PLA2G2A | |
| SCHEMBL148656 | 1.00 | EPHX1 (0.59) | EPHX1ZDHHC20ZDHHC2CASP2PLA2G2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 542 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1902077-B2 | NEUTRALISED CATIONIC POLYMER, COMPOSITION CONTAINING SAID POLYMER AND A COSMETIC TREATMENT METHOD | OREAL (FR) | 2018-07-18 | — | — | EP | claimed |
| EP-2794672-B1 | METHOD OF PREPARING ACRYLIC POLYMERS AND PRODUCTS PRODUCED THEREBY | LUBRIZOL ADVANCED MAT INC (US) | 2016-03-23 | — | — | EP | claimed |
| EP-1902077-B1 | NEUTRALISED CATIONIC POLYMER, COMPOSITION CONTAINING SAID POLYMER AND A COSMETIC TREATMENT METHOD | OREAL (FR) | 2011-11-16 | — | — | EP | claimed |
| WO-2011133072-A1 | ARRANGEMENT FOR OPERATING A HYDRAULIC DEVICE | PARKER HANNIFIN AB (SE) | 2011-10-27 | — | — | WO | claimed |
| EP-1902077-A1 | NEUTRALISED CATIONIC POLYMER, COMPOSITION CONTAINING SAID POLYMER AND A COSMETIC TREATMENT METHOD | L'Oréal (FR) | 2008-03-26 | — | — | EP | claimed |
| WO-2007003784-A1 | NEUTRALISED CATIONIC POLYMER, COMPOSITION CONTAINING SAID POLYMER AND A COSMETIC TREATMENT METHOD | L'OREAL (FR) | 2007-01-11 | — | — | WO | claimed |
| WO-2006005823-A1 | DISPERSION OF ETHYLENE POLYMER PARTICLES, COMPOSITION CONTAINING SAME AND TREATMENT METHOD | L'OREAL (FR) | 2006-01-19 | — | — | WO | claimed |
| WO-2006005824-A1 | DISPERSION OF ETHYLENE POLYMER PARTICLES, COMPOSITION CONTAINING SAME AND TREATMENT METHOD | L'ORÉAL (FR) | 2006-01-19 | — | — | WO | claimed |
| WO-2006000658-A1 | DISPERSION OF ETHYLENE POLYMER PARTICLES, COMPOSITION CONTAINING SAME AND METHOD FOR TREATMENT | L'OREAL (FR) | 2006-01-05 | — | — | WO | claimed |
| US-20250032398-A1 | HIGH MOLECULAR WEIGHT BLOCK COPOLYMERS COMPRISING REPEATING UNITS DERIVED FROM MONOMERS COMPRISING LACTAM AND ACRYLOYL MOIETIES AND HYDROPHILIC MONOMERS, COMPOSITIONS, AND APPLICATIONS THEREOF | ISP INVESTMENTS LLC (US) | 2025-01-30 | — | — | US | disclosed |
| EP-3728512-B1 | AQUEOUS FORMULATIONS OF SURFACTANTS AND ASSOCIATIVE POLYMERS FOR THE ASSISTED RECOVERY OF PETROLEUM | ENERGY SOLUTIONS US LLC (US) | 2024-07-03 | — | — | EP | disclosed |
| EP-3774958-B1 | GELLED AQUEOUS COMPOSITION FOR OIL EXTRACTION | ENERGY SOLUTIONS US LLC (US) | 2024-06-05 | — | — | EP | disclosed |
| EP-4370567-A1 | PREPARATION OF AMPHIPHILIC BLOCK POLYMERS BY REVERSE RADICAL MICELLAR POLYMERISATION | SPECIALTY OPERATIONS FRANCE (FR) | 2024-05-22 | — | — | EP | disclosed |
| WO-2024085570-A1 | FLUORINE-BASED POLYMER AND METHOD FOR PREPARING SAME | 한국화학연구원 | 2024-04-25 | — | — | WO | disclosed |
| EP-0992235-A1 | Cometic composition | BASF AKTIENGESELLSCHAFT (DE) | 2000-04-12 | — | — | EP | disclosed |
| US-5912294-A | Aqueous polymer emulsion, processes of making said aqueous polymer emulsion and methods of using said aqueous polymer emulsion | BASF AKTIENGESELLSCHAFT (DE) | 1999-06-15 | — | — | US | disclosed |
| EP-0736547-B1 | Aqueous polymer dispersions | BASF AG (DE) | 1998-10-07 | — | — | EP | disclosed |
| EP-0714415-B1 | AQUEOUS COPOLYMER DISPERSIONS | BASF AG (DE) | 1998-06-17 | — | — | EP | disclosed |
| EP-0736546-A2 | Aqueous polymer dispersions | BASF AKTIENGESELLSCHAFT (DE) | 1996-10-09 | — | — | EP | disclosed |
| EP-0736547-A2 | Aqueous polymer dispersions | BASF AKTIENGESELLSCHAFT (DE) | 1996-10-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250032398-A1 | HIGH MOLECULAR WEIGHT BLOCK COPOLYMERS COMPRISING REPEATING UNITS DERIVED FROM MONOMERS COMPRISING LACTAM AND ACRYLOYL MOIETIES AND HYDROPHILIC MONOMERS, COMPOSITIONS, AND APPLICATIONS THEREOF | PCNA, ADSL, APH1B | EPHX1 2042/4885ZDHHC20 579/4885ZDHHC2 1141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.